Merrill Lynch has worked on its second deal in a week with Boots, the UK retailer, after advising Reckitt Benckiser on its £1.9bn (€2.8bn) purchase of Boots' over-the-counter medicines business.

On Monday, the bank advised Alliance Unichem, the pharmacy chain, on its £7bn (€5.8bn) nil-premium merger with Boots.